03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Respiratory (asthma/COPD)
Sharon Barr, Ph.D.: no photograph is held, so the sector leader plate is shown instead.
Sector leader
Sharon Barr, Ph.D.
Executive Vice President for Biopharmaceuticals R&D, AstraZeneca
July 2026Aug 2026Sept 2026Oct 2026Nov 2026to date
1
Quoted in the press, across 1 topic since 8 Jul 2026
02 Quoted on · 1 of 29 topics
Sharon Barr, Ph.D.: key facts
- Kind of voice
- Sector leader
- Role
- Executive Vice President for Biopharmaceuticals R&D, AstraZeneca
- Quoted on
- Respiratory (asthma/COPD)
- Press coverage
- Quoted in the press
- Most recently quoted
- 8 Sept 2026
- First quoted
- 8 Jul 2026
04 The signal · where Sharon Barr, Ph.D. sits on respiratory (asthma/copd)
Quoted
Quoted in the press on respiratory (asthma/copd).
Placed by press coverage on this topic only, not across all topics.
Dr Andy WhittamoreClinicianClinical Lead (and practising GP), Asthma + Lung UKLeading- Dr Amina Al-YassinClinicianClinical Lead for Children and Young People's Services at Brent Integrated Care PartnershipLeading
- Are HolmAcademicHead of the Department of Respiratory Medicine at Oslo University Hospital RikshospitaletLeading
- Dr Divya KathikeyanAcademicgeneral practitioner at TelDoc
- Dr Roger MalcolmsonClinicianconsultant paediatric pathologist
- Sharon Barr, Ph.D.Sector leaderExecutive Vice President for Biopharmaceuticals R&D, AstraZeneca
- Emma RubachSector leaderhead of health advice at Asthma and Lung UK
- Joanne ThompsonAcademicmatron in respiratory specialist services
Showing the leading voices and those placed around Sharon Barr, Ph.D. · See every voice on the topic →
05 On the record · press
What Sharon Barr, Ph.D. has said
By outlet · bar length shows relative volume
- emjreviews.com
- fiercebiotech.com
Where Sharon Barr, Ph.D. has been quoted
- AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPDfiercebiotech.com · 8 Sept 2026
- AstraZeneca bets $200m on Chinese COPD drugemjreviews.com · 8 Jul 2026
How we found the articles that name Sharon Barr, Ph.D.: we searched news for these terms.
- asthma
- COPD
- respiratory disease
- lung cancer screening
- pulmonary
Also searched with “asthma” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Respiratory (asthma/COPD)
Verbatim
“it's the details that make this even more exciting than the high-level results that we've already shared.”
“many people with COPD "continue to experience exacerbations despite existing therapies", and that the new drug could offer an important additional option for patients”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Asthma Salbutamol blue inhaler reminder as pharmacist issues messageWales Online
- UK pharmacist Salbutamol reminder for anyone taking blue inhaler for asthmaThe Mirror
- Fallowfield Grandad shares shock at being diagnosed with lung cancer despite having no symptoms – now he’s helping scientists look for cancer clues hidden in bloodAbout Manchester
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.